NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19 https://www.nih.gov/news-events/news-releases/nih-activ-initiative-launches-adaptive-clinical-trials-blood-clotting-treatments-covid-19
Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party https://www.nature.com/articles/s41409-020-01173-x
ZTrials Instagram:
https://www.instagram.com/p/CITpvufjojH/?utm_source=ig_web_copy_link